Hurley Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Sell
17,357
-43
-0.2% -$4.41K 0.9% 25
2025
Q4
$1.85M Buy
17,400
+457
+3% +$53K 1.03% 26
2025
Q3
$2.15M Buy
16,943
+5
+0% +$595 1.21% 20
2025
Q2
$2.08M Sell
16,938
-483
-3% -$55.2K 1.46% 17
2025
Q1
$1.76M Sell
17,421
-2,805
-14% -$274K 1.34% 18
2024
Q4
$1.84M Buy
+20,226
New +$1.99M 1.48% 20
2015
Q3
$8.52M Buy
234,253
+276
+0.1% +$9.61K 9.89% 2
2015
Q2
$8.57M Sell
233,977
-23,711
-9% -$845K 10.41% 2
2015
Q1
$9.04M Sell
257,688
-46,377
-15% -$1.59M 11.92% 2
2014
Q4
$9.3M Buy
+304,065
New +$9.48M 12.93% 2

Other funds holding EHC

Hurley Capital's EHC Position: Q1 2026 in Review

Hurley Capital reduced its Encompass Health (EHC) stake by 0.25% in Q1 2026, selling an estimated $4.41K and leaving 17,357 shares worth $1.68M. The position accounts for 0.9% of the portfolio, ranked #25.

Hurley Capital first reported a position in EHC in Q4 2014 and has held it in 10 quarters since. The position peaked at $9.3M in Q4 2014. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Hurley Capital held 17,357 shares of Encompass Health worth $1.68M as of Q1 2026.
  • Hurley Capital sold 43 Encompass Health shares in Q1 2026, an estimated $4.41K.
  • Encompass Health made up 0.9% of Hurley Capital's portfolio in Q1 2026, its #25 holding.
  • Hurley Capital first reported a position in Encompass Health in Q4 2014 and has held it in 10 quarters since.
  • Hurley Capital's Encompass Health position peaked at $9.3M in Q4 2014.
  • 578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.